The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Loss of function of the tuberous sclerosis 2 tumor suppressor gene results in embryonic lethality characterized by disrupted neuroepithelial growth and development
Abstract
Germline defects in the tuberous sclerosis 2 (TSC2) tumor suppressor gene predispose humans and rats to benign and malignant lesions in a variety of tissues. The brain is among the most profoundly affected organs in tuberous sclerosis (TSC) patients and is the site of development of the cortical tubers for which the hereditary syndrome is named. A spontaneous germline inactivation of the Tsc2 locus has been described in an animal model, the Eker rat. We report that the homozygous state of this mutation (Tsc2 Ek/Ek ) was lethal in mid-gestation (the equivalent of mouse E9.5–E13.5), when Tsc2 mRNA was highly expressed in embryonic neuroepithelium. During this period homozygous mutant Eker embryos lacking functional Tsc2 gene product, tuberin, displayed dysraphia and papillary overgrowth of the neuroepithelium, indicating that loss of tuberin disrupted the normal development of this tissue. Interestingly, there was significant intraspecies variability in the penetrance of cranial abnormalities in mutant embryos: the Long–Evans strain Tsc2 Ek/Ek embryos displayed these defects whereas the Fisher 344 homozygous mutant embryos had normal-appearing neuroepithelium. Taken together, our data indicate that the Tsc2 gene participates in normal brain development and suggest the inactivation of this gene may have similar functional consequences in both mature and embryonic brain.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Homozygous deletion is embryonically lethal in both mice and rats, thus, heterozygous TSC models are used [90, 91].”
From Behavioral phenotyping identifies autism-like repetitive stereotypies in a Tsc2 haploinsufficient rat model (2025) · cites this paper as [91]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Identification of the Tuberous Sclerosis Gene TSC1 on Chromosome 9q34
Slegtenhorst, M. V., Hoogt, R. D., Hermans, C., Nellist, M., Janssen, B., Verhoef, S., Lindhout, D., Ouweland, A. V. D., Halley, D., Young, J., et al. (1997) · Science · doi:10.1126/science.277.5327.805 · Cited by 1,648
Identification and characterization of the tuberous sclerosis gene on chromosome 16
(1993) · Cell · doi:10.1016/0092-8674(93)90618-z · Cited by 1,645
Mapping of a major genetic modifier of embryonic lethality in TGFβ1 knockout mice
Bonyadi, M., Rusholme, S. A. B., Cousins, F. M., Su, H. C., Biron, C. A., Farrall, M., & Akhurst, R. J. (1997) · Nature Genetics · doi:10.1038/ng0297-207 · Cited by 166
Research works printed but not linked: 39
- 10.1038/ng0294-193 · DOI · Paper page
- 10.1093/hmg/5.2.249 · DOI
- 10.1136/jmg.33.11.962 · DOI · Paper page
- 10.1073/pnas.91.24.11413 · DOI · Paper page
- 10.1038/ng0195-70 · DOI · Paper page
- M R Gomez Tuberous Sclerosis (Raven, 2nd Ed., New York, 1988).
- 10.1002/(SICI)1098-2264(199601)15:1<18::AID-GCC3>3.0.CO;2-7 · DOI
- J Bjornsson, M P Short, D J Kwiatkowski, E P Henske Am J Pathol 149, 1201–1208 (1996).
- 10.1136/jmg.33.6.480 · DOI · Paper page
- 10.1073/pnas.93.17.9154 · DOI
- 10.1006/bbrc.1996.0183 · DOI
- 10.1074/jbc.270.27.16409 · DOI · Paper page
- R Wienecke, J C Maize, F Shoarinejad, W C Vass, J Reed, J S Bonifacino, J H Resau, J de Gunzburg, R S Yeung, J E DeClue Oncogene 13, 913–923 (1996).
- 10.1074/jbc.272.10.6097 · DOI · Paper page
- 10.3109/01913128009141432 · DOI
- 10.1007/BF00315012 · DOI
- E P Henske, B W Scheithauer, M P Short, R Wollmann, J Nahmias, M Hornigold, M van Slegtenhorst, C T Welsh, J Kwiatkowski Am J Hum Genet 59, 400–406 (1996).
- E P Henske, L Wessner, J Golden, B W Scheithauer, A Volkmeyer, P Zuang, A J Klein-Szanto, D J Kwiatkowski, R S Yeung Am J Path 151, 1639–1647 (1997).
- 10.1073/pnas.68.4.820 · DOI · Paper page
- 10.1038/189858b0 · DOI · Paper page
- R Eker, J Mossige, J V Johannessen, H Aars Diagn Histopathol 4, 99–110 (1981).
- 10.1016/S0022-5347(17)37087-8 · DOI
- 10.1016/0304-3835(94)90307-7 · DOI
- R S Yeung, C D Katsetos, A J Klein-Szanto Am J Path 151, 1477–1486 (1997).
- 10.1002/mc.2940140107 · DOI
- Y Kubo, H Mitani, O Hino Cancer Res 54, 2633–2635 (1994).
- 10.1073/pnas.90.1.327 · DOI · Paper page
- G H Xiao, F Jin, R S Yueng Oncogene 11, 81–87 (1995).
- , ed F M Ausubel (Wiley, New York Current Protocols in Molecular Biology, 1994).
- 10.1179/his.1989.12.3.169 · DOI · Paper page
- R Geist, D H Gutman Cell Growth Differ 6, 1477–1483 (1995).
- 10.1006/nbdi.1996.0011 · DOI
- 10.1073/pnas.93.24.14152 · DOI · Paper page
- 10.1016/0092-8674(93)90484-8 · DOI · Paper page
- C J Kemp, N R Drinkwater Cancer Res 49, 5044–5047 (1989).
- C J Moen, M Snoek, A A Hart, P Demant Oncogene 7, 563–566 (1992).
- M Obata, H Nishimori, K Ogawa, G H Lee Oncogene 13, 1599–1604 (1996).
- 10.1073/pnas.93.16.8460 · DOI · Paper page
- 10.1073/pnas.94.8.3990 · DOI
Cited by
Brugarolas, J., Lei, K., Hurley, R. L., Manning, B. D., Reiling, J. H., Hafen, E., Witters, L. A., Ellisen, L. W., & Kaelin, W. G. (2004) · Genes & Development · doi:10.1101/gad.1256804 · Cited by 1,384
“5 of gestation when it is difficult to obtain a large number of fibroblasts (Rennebeck et al. 1998).”
BackgroundInfluentialYu, J. S. L., & Cui, W. (2016) · Development · doi:10.1242/dev.137075 · Cited by 1,135
TSC2 regulates VEGF through mTOR-dependent and -independent pathways
Brugarolas, J. B., Vazquez, F., Reddy, A., Sellers, W. R., & Kaelin, W. G. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00187-9 · Cited by 528
TSC1 and TSC2 tumor suppressors antagonize insulin signaling in cell growth
Gao, X., & Pan, D. (2001) · Genes & Development · doi:10.1101/gad.901101 · Cited by 455
Tuberin Regulates p70 S6 Kinase Activation and Ribosomal Protein S6 Phosphorylation
Goncharova, E. A., Goncharov, D. A., Eszterhas, A., Hunter, D. S., Glassberg, M. K., Yeung, R. S., Walker, C. L., Noonan, D., Kwiatkowski, D. J., Chou, M. M., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m202678200 · Cited by 425
Self-citation
Metadata
- Authors
- Rennebeck, G., Kleymenova, E. V., Anderson, R., Yeung, R. S., Artzt, K., & Walker, C. L.
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 1998-12-22
- Volume
- 95
- Issue
- 26
- Pages
- 15629-15634
- ISSN
- 0027-8424
- 1091-6490
- Cited by
- 92
- References
- 3
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Loss of function of the tuberous sclerosis 2 tumor suppressor gene results in embryonic lethality characterized by disrupted neuroepithelial growth and development. https://app.cochat.ai/papers/10.1073/pnas.95.26.15629
- The paper
- Rennebeck, G., Kleymenova, E. V., Anderson, R., Yeung, R. S., Artzt, K., & Walker, C. L. (1998). Loss of function of the tuberous sclerosis 2 tumor suppressor gene results in embryonic lethality characterized by disrupted neuroepithelial growth and development. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.95.26.15629
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.